Dapagliflozin treatment and cardiovascular outcome in RBP4/TTRVal30Met (transthyretin cardiac amyloidosis) mice

Zonglin Li, Fang Lv, Xin Wen, Chengcheng Guo, Li Li, Xiaoling Cai*, Chu Lin, Mengqing Zhang, Wenjia Yang, Linong Ji*

*此作品的通讯作者

科研成果: 期刊稿件 › 文章 › 同行评审

2 引用 （Scopus）

指纹

探究 'Dapagliflozin treatment and cardiovascular outcome in RBP4/TTRVal30Met (transthyretin cardiac amyloidosis) mice' 的科研主题。它们共同构成独一无二的指纹。

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science